Literature DB >> 20534510

Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex.

Ann Hye-Ryong Shim1, Heli Liu, Pamela J Focia, Xiaoyan Chen, P Charles Lin, Xiaolin He.   

Abstract

Platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are prototypic growth factors and receptor tyrosine kinases which have critical functions in development. We show that PDGFs share a conserved region in their prodomain sequences which can remain noncovalently associated with the mature cystine-knot growth factor domain after processing. The structure of the PDGF-A/propeptide complex reveals this conserved, hydrophobic association mode. We also present the structure of the complex between PDGF-B and the first three Ig domains of PDGFRbeta, showing that two PDGF-B protomers clamp PDGFRbeta at their dimerization seam. The PDGF-B:PDGFRbeta interface is predominantly hydrophobic, and PDGFRs and the PDGF propeptides occupy overlapping positions on mature PDGFs, rationalizing the need of propeptides by PDGFs to cover functionally important hydrophobic surfaces during secretion. A large-scale structural organization and rearrangement is observed for PDGF-B upon receptor binding, in which the PDGF-B L1 loop, disordered in the structure of the free form, adopts a highly specific conformation to form hydrophobic interactions with the third Ig domain of PDGFRbeta. Calorimetric data also shows that the membrane-proximal homotypic PDGFRalpha interaction, albeit required for activation, contributes negatively to ligand binding. The structural and biochemical data together offer insights into PDGF-PDGFR signaling, as well as strategies for PDGF-antagonism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534510      PMCID: PMC2895058          DOI: 10.1073/pnas.1000806107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  Five PDGF B amino acid substitutions convert PDGF A to a PDGF B-like transforming molecule.

Authors:  W J LaRochelle; J H Pierce; M May-Siroff; N Giese; S A Aaronson
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

Review 3.  The PDGF family: four gene products form five dimeric isoforms.

Authors:  Linda Fredriksson; Hong Li; Ulf Eriksson
Journal:  Cytokine Growth Factor Rev       Date:  2004-08       Impact factor: 7.638

4.  Platelets as a source of fibroblast growth-promoting activity.

Authors:  N Kohler; A Lipton
Journal:  Exp Cell Res       Date:  1974-08       Impact factor: 3.905

5.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro.

Authors:  R Ross; J Glomset; B Kariya; L Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

6.  VEGF-Trap: a VEGF blocker with potent antitumor effects.

Authors:  Jocelyn Holash; Sam Davis; Nick Papadopoulos; Susan D Croll; Lillian Ho; Michelle Russell; Patricia Boland; Ray Leidich; Donna Hylton; Elena Burova; Ella Ioffe; Tammy Huang; Czeslaw Radziejewski; Kevin Bailey; James P Fandl; Tom Daly; Stanley J Wiegand; George D Yancopoulos; John S Rudge
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

7.  Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.

Authors:  Ralf Erber; Andreas Thurnher; Alice D Katsen; Gesine Groth; Heinz Kerger; Hans-Peter Hammes; Michael D Menger; Axel Ullrich; Peter Vajkoczy
Journal:  FASEB J       Date:  2003-12-04       Impact factor: 5.191

8.  Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.

Authors:  Gabriele Bergers; Steven Song; Nicole Meyer-Morse; Emily Bergsland; Douglas Hanahan
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 9.  PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma.

Authors:  Arne Ostman
Journal:  Cytokine Growth Factor Rev       Date:  2004-08       Impact factor: 7.638

10.  Two PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activation.

Authors:  J M Clements; L J Bawden; R E Bloxidge; G Catlin; A L Cook; S Craig; A H Drummond; R M Edwards; A Fallon; D R Green
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  55 in total

Review 1.  Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors.

Authors:  Christopher C Valley; Andrew K Lewis; Jonathan N Sachs
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-12       Impact factor: 3.747

Review 2.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

Review 3.  The emerging complexity of PDGFRs: activation, internalization and signal attenuation.

Authors:  Madison A Rogers; Katherine A Fantauzzo
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

Review 4.  Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases.

Authors:  Kenneth Verstraete; Savvas N Savvides
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

5.  Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets.

Authors:  Douglas R Davies; Amy D Gelinas; Chi Zhang; John C Rohloff; Jeffrey D Carter; Daniel O'Connell; Sheela M Waugh; Steven K Wolk; Wesley S Mayfield; Alex B Burgin; Thomas E Edwards; Lance J Stewart; Larry Gold; Nebojsa Janjic; Thale C Jarvis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-08       Impact factor: 11.205

Review 6.  Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation.

Authors:  Rui Zhang; Wan Zhu; Hua Su
Journal:  Acta Neurochir Suppl       Date:  2016

Review 7.  Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.

Authors:  Kathryn M Ferguson; Chun Hu; Mark A Lemmon
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

Review 8.  Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.

Authors:  Sebastian A Lewandowski; Linda Fredriksson; Daniel A Lawrence; Ulf Eriksson
Journal:  Pharmacol Ther       Date:  2016-08-12       Impact factor: 12.310

9.  Development of a Peptide Derived from Platelet-Derived Growth Factor (PDGF-BB) into a Potential Drug Candidate for the Treatment of Wounds.

Authors:  Milena Deptuła; Przemysław Karpowicz; Anna Wardowska; Piotr Sass; Paweł Sosnowski; Alina Mieczkowska; Natalia Filipowicz; Maria Dzierżyńska; Justyna Sawicka; Ewa Nowicka; Paulina Langa; Adriana Schumacher; Mirosława Cichorek; Jacek Zieliński; Karolina Kondej; Franciszek Kasprzykowski; Artur Czupryn; Łukasz Janus; Piotr Mucha; Piotr Skowron; Arkadiusz Piotrowski; Paweł Sachadyn; Sylwia Rodziewicz-Motowidło; Michał Pikuła
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-10-29       Impact factor: 4.730

10.  Vascular PDGFR-alpha protects against BBB dysfunction after stroke in mice.

Authors:  Quang Linh Nguyen; Noriko Okuno; Takeru Hamashima; Son Tung Dang; Miwa Fujikawa; Yoko Ishii; Atsushi Enomoto; Takakuni Maki; Hoang Ngoc Nguyen; Van Tuyen Nguyen; Toshihiko Fujimori; Hisashi Mori; Johanna Andrae; Christer Betsholtz; Keizo Takao; Seiji Yamamoto; Masakiyo Sasahara
Journal:  Angiogenesis       Date:  2020-09-12       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.